Beth Israel Deacnss Medical Center Oncology — Boston, Massachusetts

Beth Israel Deacnss Medical Center Oncology is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Beth Israel Deacnss Medical Center Oncology has participated in 1 clinical trials.

Therapeutic areas: Newly Diagnosed FLT3 Mutated AML.

Sponsors: Arog Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deacnss Medical Center Oncology?

Beth Israel Deacnss Medical Center Oncology has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deacnss Medical Center Oncology conducted?

Beth Israel Deacnss Medical Center Oncology has 1 clinical trials on record. Their work covers Newly Diagnosed FLT3 Mutated AML.

Is Beth Israel Deacnss Medical Center Oncology accredited by Crixeo Health?

Beth Israel Deacnss Medical Center Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Israel Deacnss Medical Center Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.